Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
Intervention1: nigella sativa supplements along with the medication: Participants in this group will receive Nigella sativa capsules at a dose of 1 gram per day,
administered orally in divided doses (
Sponsors
Dr Vasanthkumar A
Eligibility
Inclusion criteria
Inclusion criteria: 1.Individuals with type II Diabetes Mellitus and those who are on oral anti-diabetic therapy. 2. Diagnosed with Type-2 Diabetes Mellitus for more than 5 years. 3. Individuals whose HbAlc between 6% and 10% 4.Positive microalbuminuria (confirmed by a positive UACR readings) 5. Willingness to participate in the research
Exclusion criteria
Exclusion criteria: 1.History of Kidney or liver failure 2.Type 1 diabetes 3.CKD stage 3 or above 4.Use of herbal supplements including nigella sativa in the past 3 months 5.Patient under medication o f S G LT 2 inhibitors 6.Pregnant or lactating women 7.Individuals under insulin therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the impact of Nigella sativa supplementation on urinary microalbumin levels in type 2 diabetes individuals .Timepoint: Baseline, 3 months after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the effect of Nigella sativa supplementation on fasting blood glucose, post prandial blood glucose and HbA1c levels in patients with type 2 diabetes.Timepoint: Baseline, 3 months after the intervention | — |
Countries
India
Contacts
Public ContactDr Geetha B Shetty
Sri Dharmasthala Manjunatheshwara college of naturopathy and yogic sciences
Outcome results
None listed